Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김대기 | * |
dc.date.accessioned | 2016-08-28T12:08:24Z | - |
dc.date.available | 2016-08-28T12:08:24Z | - |
dc.date.issued | 2010 | * |
dc.identifier.issn | 0960-894X | * |
dc.identifier.other | OAK-6679 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/220873 | - |
dc.description.abstract | A series of 2-pyridyl-substituted pyrazoles (16a-d, 17, 18, and 28a-e) and imidazoles (22 and 23) has been synthesized and evaluated for their ALK5 inhibitory activity in cell-based luciferase reporter assays. Among them, 3-(3-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)-1H-pyrazole-1-carbothioamido)benzamide (28c) showed 96% and 93% inhibition at 0.1 μM in luciferase reporter assays using HaCaT cells transiently transfected with p3TP-luc reporter construct and ARE-luc reporter construct, respectively. © 2010 Elsevier Ltd. All rights reserved. | * |
dc.language | English | * |
dc.title | Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors | * |
dc.type | Article | * |
dc.relation.issue | 14 | * |
dc.relation.volume | 20 | * |
dc.relation.index | SCI | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 4228 | * |
dc.relation.lastpage | 4232 | * |
dc.relation.journaltitle | Bioorganic and Medicinal Chemistry Letters | * |
dc.identifier.doi | 10.1016/j.bmcl.2010.05.032 | * |
dc.identifier.wosid | WOS:000279258800053 | * |
dc.identifier.scopusid | 2-s2.0-77953873137 | * |
dc.author.google | Dewang P.M. | * |
dc.author.google | Kim D.-K. | * |
dc.contributor.scopusid | 김대기(35083694200) | * |
dc.date.modifydate | 20240118164500 | * |